Auron Therapeutics is a verified, high-potential Series B biotechnology company (raised ~$104M) developing novel oncology therapies (IND cleared for AUTX-703). However, the project submission itself contains significant inaccuracies and low-quality data (e.g., claiming 'everyone' as audience and 'most people' have used it, which contradicts its clinical stage). The 'marketcap: 500000' entry likely omits zeros (possibly intending $500M valuation). The score reflects the high verifiable utility and innovation of the entity, penalized by the poor quality and dubious claims of the submission form.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline